143
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Vitamin D Signaling Pathways Confer the Susceptibility of Esophageal Squamous Cell Carcinoma in a Northern Chinese Population

, , , , , , & show all
Pages 593-600 | Received 02 Apr 2016, Accepted 17 Jan 2017, Published online: 31 Mar 2017

References

  • Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, et al.: Global cancer statistics, 2012. CA Cancer J Clin 65, 87–108, 2015.
  • Rustgi AK, El-Serag HB: Esophageal carcinoma. N Engl J Med 371, 2499–2509, 2014.
  • Wu M, Liu AM, Kampman E, Zhang ZF, Van't Veer P, et al.: Green tea drinking, high tea temperature and esophageal cancer in high- and low-risk areas of Jiangsu Province, China: a population-based case-control study. Int J Cancer 124, 1907–1913, 2009.
  • Sun X, Chen W, Chen Z, Wen D, Zhao D, et al.: Population-based case-control study on risk factors for esophageal cancer in five high-risk areas in China. Asian Pac J Cancer Prev 11, 1631–1636, 2010.
  • Zou XN, Taylor PR, Mark SD, Chao A, Wang W, et al.: Seasonal variation of food consumption and selected nutrient intake in Linxian, a high risk area for esophageal cancer in China. Int J Vitam Nutr Res 72, 375–382, 2002.
  • Castro C, Bosetti C, Malvezzi M, Bertuccio P, Levi F, et al.: Patterns and trends in esophageal cancer mortality and incidence in Europe (1980–2011) and predictions to 2015. Ann Oncol 25, 283–290, 2014.
  • Okano T, Yasumura M, Mizuno K, Kobayashi T: In vivo and in vitro conversion of 7-dehydrocholesterol into vitamin D3 in rat skin by ultraviolet ray's irradiation. J Nutr Sci Vitaminol (Tokyo) 24, 47–56, 1978.
  • Norman AW: From vitamin D to hormone D: fundamentals of the vitamin D endocrine system essential for good health. Am J Clin Nutr 88, 491S–499S, 2008.
  • Powe CE, Ricciardi C, Berg AH, Erdenesanaa D, Collerone G, et al.: Vitamin D-binding protein modifies the vitamin D-bone mineral density relationship. J Bone Miner Res 26, 1609–1616, 2011.
  • Takeyama K, Kitanaka S, Sato T, Kobori M, Yanagisawa J, et al.: 25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis. Science 277, 1827–1830, 1997.
  • Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, et al.: The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 13, 325–349, 1998.
  • Deeb KK, Trump DL, Johnson CS: Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7, 684–700, 2007.
  • Godar DE, Pope SJ, Grant WB, Holick MF: Solar UV doses of young Americans and vitamin D3 production. Environ Health Perspect 120, 139–143, 2012.
  • Gu H, Wang X, Zheng L, Tang W, Dong C, et al.: Vitamin D receptor gene polymorphisms and esophageal cancer risk in a Chinese population: a negative study. Med Oncol 31, 827, 2014.
  • Chang CK, Mulholland HG, Cantwell MM, Anderson LA, Johnston BT, et al.: Vitamin d receptor gene variants and esophageal adenocarcinoma risk: a population-based case-control study. J Gastrointest Cancer 43, 512–517, 2012.
  • Li D, Diao Y, Li H, Fang X: Association of the polymorphisms of MTHFR C677T, VDR C352T, and MPO G463A with risk for esophageal squamous cell dysplasia and carcinoma. Arch Med Res 39, 594–600, 2008.
  • Helzlsouer KJ, Gallicchio L: Shedding light on serum vitamin D concentrations and the risk of rarer cancers. Anticancer Agents Med Chem 13, 65–69, 2013.
  • Abnet CC, Chen Y, Chow WH, Gao YT, Helzlsouer KJ, et al.: Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: Cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol 172, 94–106, 2010.
  • McCullough ML, Weinstein SJ, Freedman DM, Helzlsouer K, Flanders WD, et al.: Correlates of circulating 25-hydroxyvitamin D: cohort consortium vitamin D pooling project of rarer cancers. Am J Epidemiol 172, 21–35, 2010.
  • Chen W, Dawsey SM, Qiao YL, Mark SD, Dong ZW, et al.: Prospective study of serum 25(OH)-vitamin D concentration and risk of oesophageal and gastric cancers. Br J Cancer 97, 123–128, 2007.
  • Chen P, Liang J, Wang Z, Zhou X, Chen L, et al.: Association of common PALB2 polymorphisms with breast cancer risk: a case-control study. Clin Cancer Res 14, 5931–5937, 2008.
  • Freedman ND, Park Y, Subar AF, Hollenbeck AR, Leitzmann MF, et al.: Fruit and vegetable intake and esophageal cancer in a large prospective cohort study. Int J Cancer 121, 2753–2760, 2007.
  • Thurnham DI, Zheng SF, Munoz N, Crespi M, Grassi A, et al.: Comparison of riboflavin, vitamin A, and zinc status of Chinese populations at high and low risk for esophageal cancer. Nutr Cancer 7, 131–143, 1985.
  • Bo Y, Lu Y, Zhao Y, Zhao E, Yuan L, et al.: Association between dietary vitamin C intake and risk of esophageal cancer: A dose-response meta-analysis. Int J Cancer, 2015.
  • Xiao Q, Freedman ND, Ren J, Hollenbeck AR, Abnet CC, et al.: Intakes of folate, methionine, vitamin B6, and vitamin B12 with risk of esophageal and gastric cancer in a large cohort study. Br J Cancer 110, 1328–1333, 2014.
  • Li JY, Taylor PR, Li B, Dawsey S, Wang GQ, et al.: Nutrition intervention trials in Linxian, China: multiple vitamin/mineral supplementation, cancer incidence, and disease-specific mortality among adults with esophageal dysplasia. J Natl Cancer Inst 85, 1492–1498, 1993.
  • Bauer SR, Hankinson SE, Bertone-Johnson ER, Ding EL: Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies. Medicine (Baltimore) 92, 123–131, 2013.
  • Chen P, Hu P, Xie D, Qin Y, Wang F, et al.: Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat 121, 469–477, 2010.
  • Ma Y, Zhang P, Wang F, Yang J, Liu Z, et al.: Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin Oncol 29, 3775–3782, 2011.
  • Zhang L, Wang S, Che X, Li X: Vitamin D and lung cancer risk: a comprehensive review and meta-analysis. Cell Physiol Biochem 36, 299–305, 2015.
  • Chen Y, Liu W, Sun T, et al.: 1,25-Dihydroxyvitamin D promotes negative feedback regulation of TLR signaling via targeting microRNA-155-SOCS1 in macrophages. J Immunol 190, 3687–3695, 2013.
  • Fu B, Wang H, Wang J, et al.: Epigenetic regulation of BMP2 by1,25-dihydroxyvitamin D3 through DNA methylation and histone modification. PLoS ONE 8, e61423, 2013.
  • Chen PT, Hsieh CC, Wu CT, Yen TC, Lin PY, et al.: 1alpha,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling. Mol Cancer Ther 14, 1365–1375, 2015.
  • Abnet CC, Chen W, Dawsey SM, Wei WQ, Roth MJ, et al.: Serum 25(OH)-vitamin D concentration and risk of esophageal squamous dysplasia. Cancer Epidemiol Biomarkers Prev 16, 1889–1893, 2007.
  • Lipworth L, Rossi M, McLaughlin JK, Negri E, Talamini R, et al.: Dietary vitamin D and cancers of the oral cavity and esophagus. Ann Oncol 20, 1576–1581, 2009.
  • Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, et al.: Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 98, 451–459, 2006.
  • Mun MJ, Kim TH, Hwang JY, Jang WC: Vitamin D receptor gene polymorphisms and the risk for female reproductive cancers: A meta-analysis. Maturitas 81, 256–265, 2015.
  • Hou W, Wan X, Fan J: Variants Fok1 and Bsm1 on VDR are associated with the melanoma risk: evidence from the published epidemiological studies. BMC Genet 16, 14, 2015.
  • Liu Y, Li C, Chen P, Li X, Li M, et al.: Polymorphisms in the vitamin D Receptor (VDR) and the risk of ovarian cancer: a meta-analysis. PLoS ONE 8, e66716, 2013.
  • Randerson-Moor JA, Taylor JC, Elliott F, Chang YM, Beswick S, et al.: Vitamin D receptor gene polymorphisms, serum 25-hydroxyvitamin D levels, and melanoma: UK case-control comparisons and a meta-analysis of published VDR data. Eur J Cancer 45, 3271–3281, 2009.
  • Yamamoto H, Miyamoto K, Li B, Taketani Y, Kitano M, et al.: The caudal-related homeodomain protein Cdx-2 regulates vitamin D receptor gene expression in the small intestine. J Bone Miner Res 14, 240–247, 1999.
  • Pulito C, Terrenato I, Di Benedetto A, Korita E, Goeman F, et al.: Cdx2 polymorphism affects the activities of vitamin D receptor in human breast cancer cell lines and human breast carcinomas. PLoS ONE 10, e0124894, 2015.
  • Wang P, Zhang H, Zhang Z, Qin L, Li B: Association of the CYP24A1-rs2296241 polymorphism of the vitamin D catabolism enzyme with hormone-related cancer risk: a meta-analysis. Onco Targets Ther 8, 1175–1183, 2015.
  • Zeljic K, Supic G, Stamenkovic Radak M, Jovic N, Kozomara R, et al.: Vitamin D receptor, CYP27B1 and CYP24A1 genes polymorphisms association with oral cancer risk and survival. J Oral Pathol Med 41, 779–787, 2012.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.